Vertex to present at upcoming investor conferences

Boston--(business wire)--vertex pharmaceuticals incorporated (nasdaq: vrtx) today announced management participation in two upcoming investor conferences. charles wagner, executive vice president and chief financial officer, and david altshuler, m.d., ph.d., executive vice president, global research, and chief scientific officer, will participate in a fireside chat at ubs biopharma conference on thursday, november 9, 2023 at 12:00 p.m. et. stuart arbuckle, executive vice president and chief ope.
VRTX Ratings Summary
VRTX Quant Ranking